388 related articles for article (PubMed ID: 26427375)
1. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Srihari S; Singla J; Wong L; Ragan MA
Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
[TBL] [Abstract][Full Text] [Related]
2. Link synthetic lethality to drug sensitivity of cancer cells.
Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
[TBL] [Abstract][Full Text] [Related]
3. TP53 mutations, expression and interaction networks in human cancers.
Wang X; Sun Q
Oncotarget; 2017 Jan; 8(1):624-643. PubMed ID: 27880943
[TBL] [Abstract][Full Text] [Related]
4. Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.
Tang YC; Ho SC; Tan E; Ng AWT; McPherson JR; Goh GYL; Teh BT; Bard F; Rozen SG
Breast Cancer Res; 2018 Mar; 20(1):22. PubMed ID: 29566768
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response.
Das S; Camphausen K; Shankavaram U
Front Oncol; 2019; 9():1136. PubMed ID: 31709193
[TBL] [Abstract][Full Text] [Related]
6. Overcoming selection bias in synthetic lethality prediction.
Seale C; Tepeli Y; Gonçalves JP
Bioinformatics; 2022 Sep; 38(18):4360-4368. PubMed ID: 35876858
[TBL] [Abstract][Full Text] [Related]
7. Multi-omic measurement of mutually exclusive loss-of-function enriches for candidate synthetic lethal gene pairs.
Wappett M; Dulak A; Yang ZR; Al-Watban A; Bradford JR; Dry JR
BMC Genomics; 2016 Jan; 17():65. PubMed ID: 26781748
[TBL] [Abstract][Full Text] [Related]
8. Ranking novel cancer driving synthetic lethal gene pairs using TCGA data.
Ye H; Zhang X; Chen Y; Liu Q; Wei J
Oncotarget; 2016 Aug; 7(34):55352-55367. PubMed ID: 27438146
[TBL] [Abstract][Full Text] [Related]
9. SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets.
Guo J; Liu H; Zheng J
Nucleic Acids Res; 2016 Jan; 44(D1):D1011-7. PubMed ID: 26516187
[TBL] [Abstract][Full Text] [Related]
10. Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality.
Benfatto S; Serçin Ö; Dejure FR; Abdollahi A; Zenke FT; Mardin BR
Mol Cancer; 2021 Aug; 20(1):111. PubMed ID: 34454516
[TBL] [Abstract][Full Text] [Related]
11. Predicting human genetic interactions from cancer genome evolution.
Lu X; Megchelenbrink W; Notebaart RA; Huynen MA
PLoS One; 2015; 10(5):e0125795. PubMed ID: 25933428
[TBL] [Abstract][Full Text] [Related]
12. Building high-resolution synthetic lethal networks: a 'Google map' of the cancer cell.
Paul JM; Templeton SD; Baharani A; Freywald A; Vizeacoumar FJ
Trends Mol Med; 2014 Dec; 20(12):704-15. PubMed ID: 25446836
[TBL] [Abstract][Full Text] [Related]
13. CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference.
Dou Y; Ren Y; Zhao X; Jin J; Xiong S; Luo L; Xu X; Yang X; Yu J; Guo L; Liang T
Comput Biol Med; 2024 Mar; 170():108066. PubMed ID: 38310806
[TBL] [Abstract][Full Text] [Related]
14. Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response.
Pinoli P; Srihari S; Wong L; Ceri S
BMC Bioinformatics; 2021 May; 22(1):250. PubMed ID: 33992077
[TBL] [Abstract][Full Text] [Related]
15. Changes in gene expression variability reveal a stable synthetic lethal interaction network in BRCA2-ovarian cancers.
Bueno R; Mar JC
Methods; 2017 Dec; 131():74-82. PubMed ID: 28754563
[TBL] [Abstract][Full Text] [Related]
16. Cross-species identification of PIP5K1-, splicing- and ubiquitin-related pathways as potential targets for RB1-deficient cells.
Parkhitko AA; Singh A; Hsieh S; Hu Y; Binari R; Lord CJ; Hannenhalli S; Ryan CJ; Perrimon N
PLoS Genet; 2021 Feb; 17(2):e1009354. PubMed ID: 33591981
[TBL] [Abstract][Full Text] [Related]
17. Malignancy of Cancers and Synthetic Lethal Interactions Associated With Mutations of Cancer Driver Genes.
Wang X; Zhang Y; Han ZG; He KY
Medicine (Baltimore); 2016 Feb; 95(8):e2697. PubMed ID: 26937901
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions.
Lord CJ; Quinn N; Ryan CJ
Elife; 2020 May; 9():. PubMed ID: 32463358
[TBL] [Abstract][Full Text] [Related]
19. Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.
Jerby-Arnon L; Pfetzer N; Waldman YY; McGarry L; James D; Shanks E; Seashore-Ludlow B; Weinstock A; Geiger T; Clemons PA; Gottlieb E; Ruppin E
Cell; 2014 Aug; 158(5):1199-1209. PubMed ID: 25171417
[TBL] [Abstract][Full Text] [Related]
20. SL-scan identifies synthetic lethal interactions in cancer using metabolic networks.
Zangene E; Marashi SA; Montazeri H
Sci Rep; 2023 Sep; 13(1):15763. PubMed ID: 37737478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
